[Skip to Content]
[Skip to Content Landing]
Views 2,518
Citations 0
Editorial
July 24/31, 2018

2018 IAS-USA Recommendations for the Use of Antiretroviral Therapy for HIVBuilding on Decades of Progress

Author Affiliations
  • 1Division of Infectious Diseases, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor
JAMA. 2018;320(4):347-349. doi:10.1001/jama.2018.9184

Soon after HIV was first identified as the cause of AIDS in the early 1980s, it became clear that antiretroviral treatments were needed to prevent the development of opportunistic infections and malignancies that were often fatal. Over the next decade into the 1990s, several therapies rapidly became available, including zidovudine and protease inhibitors such as saquinavir and indinavir. As these medications were developed, investigators learned that combinations of these drugs were needed to successfully inhibit viral replication, prevent resistance from developing, and extend life expectancy.

×